Compare Hemodynamic Effect of Oxytocin Bolus and Infusion During Cesarean Section Under Spinal Anesthesia

What Was Tested

The trial (not phased) is built around Oxytocin.

It is typically administered immediately after delivery of the baby, either as a slow intravenous bolus followed by a continuous infusion or as an infusion alone, depending on clinical protocols.

It had two arms (groups): Oxytocin bolus group (experimental) and Oxytocin infusion group (active comparator).

Patient recieving oxytocin bolus I/v during Cesarean section under spinal anesthesia.

Oxytocin iv transfusion during Cesarean section.

The registry classes the interventions as drug.

Who Took Part

The registry lists 262 planned participants were the target.

It was open to women only aged from 18 years up to 40 years.

Healthy volunteers could join, not only people with the condition.

How the Study Was Run

It was run as a randomized, parallel-group and single-blind study.

Because people in this Oxytocin study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Groups ran in parallel: each of the participants stayed in one arm throughout.

Only one side, usually the participants, was kept unaware of whether Oxytocin was given.

Those kept unaware of assignments: outcomes assessor.

It started in 2026-07-01 with completion listed for 2026-10-01.

Its stated primary purpose is prevention.

What Was Measured

Primary outcome: Heart rate and blood pressure changes in beats per minute and mmHg respectively by comparing intravenous bolus and infusion oxytocin during Cesarean section under spinal anesthesia (time frame: Over period of giving the drug and after 2 to 5 mins of giving drug).

What This Means in Plain Language

Put simply, this is a not phased, randomized trial of Oxytocin in 262 people.

Its status is not yet recruiting; no results are posted to the registry yet, so nothing here describes outcomes.

More context: the Oxytocin compound page, all human trials.